RPS-BLAST 2.2.26 [Sep-21-2011]

Database: CDD.v3.10 
           44,354 sequences; 10,937,602 total letters

Searching..................................................done

Query= psy7256
         (398 letters)



>gnl|CDD|189008 cd09601, M1_APN_2, Peptidase M1 Aminopeptidase N family incudes
           tricorn interacting factor F3, Endoplasmic reticulum
           aminopeptidase 1 (ERAP1), Aminopeptidase Q (APQ).  This
           M1 peptidase family includes eukaryotic and bacterial
           members: aminopeptidase N (APN), aminopeptidase Q (APQ,
           laeverin), endoplasmic reticulum aminopeptidase 1
           (ERAP1) as well as tricorn interacting factor F3.
           Aminopeptidase N (APN; CD13; Alanyl aminopeptidase; EC
           3.4.11.2), a Type II integral membrane protease,
           consists of a small N-terminal cytoplasmic domain, a
           single transmembrane domain and a large extracellular
           ectodomain that contains the active site. It
           preferentially cleaves neutral amino acids from the
           N-terminus of oligopeptides and is present in a variety
           of human tissues and cell types (leukocyte, fibroblast,
           endothelial and epithelial cells). APN expression is
           dysregulated in inflammatory diseases such as chronic
           pain, rheumatoid arthritis, multiple sclerosis, systemic
           sclerosis, systemic lupus erythematosus,
           polymyositis/dermatomyosytis and pulmonary sarcoidosis,
           and is enhanced in tumor cells such as melanoma, renal,
           prostate, pancreas, colon, gastric and thyroid cancers.
           It is considered a marker of differentiation since it is
           predominantly expressed on stem cells and on cells of
           the granulocytic and monocytic lineages at distinct
           stages of differentiation. Thus, APN inhibition may lead
           to the development of anti-cancer and anti-inflammatory
           drugs. ERAP1 also known as endoplasmic reticulum
           aminopeptidase associated with antigen processing
           (ERAAP), adipocyte derived leucine aminopeptidase
           (A-LAP) or aminopeptidase regulating tumor necrosis
           factor receptor I (THFRI) shedding (ARTS-1), associates
           with the closely related ER aminopeptidase ERAP2, for
           the final trimming of peptides within the ER for
           presentation by MHC class I molecules. ERAP1 is
           associated with ankylosing spondylitis (AS), an
           inflammatory arthritis that predominantly affects the
           spine. ERAP1 also aids in the shedding of membrane-bound
           cytokine receptors. The tricorn interacting factor F3,
           together with factors F1 and F2, degrades the tricorn
           protease products, producing free amino acids, thus
           completing the proteasomal degradation pathway. F3 is
           homologous to F2, but not F1, and shows a strong
           preference for glutamate in the P1' position. APQ, also
           known as laeverin, is specifically expressed in human
           embryo-derived extravillous trophoblasts (EVTs) that
           invade the uterus during early placentation. It cleaves
           the N-terminal amino acid of various peptides such as
           angiotensin III, endokinin C, and kisspeptin-10, all
           expressed in the placenta in large quantities. APN is a
           receptor for coronaviruses, although the virus receptor
           interaction site seems to be distinct from the enzymatic
           site and aminopeptidase activity is not necessary for
           viral infection. APNs are also putative Cry toxin
           receptors. Cry1 proteins are pore-forming toxins that
           bind to the midgut epithelial cell membrane of
           susceptible insect larvae, causing extensive damage.
           Several different toxins, including Cry1Aa, Cry1Ab,
           Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to
           bind to APNs; however, a direct role of APN in
           cytotoxicity has been yet to be firmly established.
          Length = 446

 Score = 67.6 bits (166), Expect = 3e-12
 Identities = 21/39 (53%), Positives = 25/39 (64%)

Query: 137 HKYGNAETKDFWSVLSKHSNHSINVKAIMDTWSRQMGFP 175
           H YGNA T D W  LS+ S    +VK IMDTW+ Q G+P
Sbjct: 408 HAYGNATTDDLWEALSEASKLGKDVKEIMDTWTLQPGYP 446


>gnl|CDD|223385 COG0308, PepN, Aminopeptidase N [Amino acid transport and
           metabolism].
          Length = 859

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 16/45 (35%), Positives = 23/45 (51%), Gaps = 2/45 (4%)

Query: 137 HKYGNAETKDFWSVLSKHSNHSINVKAIMDTWSRQMGFPVIRISR 181
           H  GNA T D W  L   S    ++ A  ++W  Q G+PV+ +S 
Sbjct: 430 HAGGNATTMDLWKALEDASG--KDLSAFFESWLSQAGYPVLTVSV 472


>gnl|CDD|234038 TIGR02865, spore_II_E, stage II sporulation protein E.  Stage II
           sporulation protein E (SpoIIE) is a multiple membrane
           spanning protein with two separable functions. It plays
           a role in the switch to polar cell division during
           sporulation. By means of it protein phosphatase
           activity, located in the C-terminal region, it activates
           sigma-F. All proteins that score above the trusted
           cutoff to this model are found in endospore-forming
           Gram-positive bacteria. Surprisingly, a sequence from
           the Cyanobacterium-like (and presumably
           non-spore-forming) photosynthesizer Heliobacillus
           mobilis is homologous, and scores between the trusted
           and noise cutoffs [Cellular processes, Sporulation and
           germination].
          Length = 764

 Score = 30.4 bits (69), Expect = 1.9
 Identities = 31/144 (21%), Positives = 50/144 (34%), Gaps = 40/144 (27%)

Query: 282 KLIMKKDNPEEKEKLE-------------WERK--YLHKIMLKFLNVVEN-IPEEGDIPS 325
           KL MK+ +    E L              W+R+  Y +  M + +  +E        +P 
Sbjct: 339 KLTMKRKSSYLLENLAERVCQSCNMKHRCWKREFDYTYSAMEELIENLEEKKDPNSKLPD 398

Query: 326 NIVRYCERFIEFNST----------------RVPSERKLLLKVKAFFKDMDVGSGARSLE 369
              R C +  E  +T                R+   R+L   V    K +     A S+E
Sbjct: 399 EFERKCIKRKELINTTEDILNNYIINEMWRKRLEEGRRL---VAEQLKGV-----AESVE 450

Query: 370 QSLETIELNIHWVRRNEEPIFQWL 393
              + I L I + +  EE I + L
Sbjct: 451 DIAKEINLEIVFHQLLEEKIIRAL 474


>gnl|CDD|233857 TIGR02412, pepN_strep_liv, aminopeptidase N, Streptomyces lividans
           type.  This family is a subset of the members of the
           zinc metallopeptidase family M1 (pfam01433), with a
           single member characterized in Streptomyces lividans 66
           and designated aminopeptidase N. The spectrum of
           activity may differ somewhat from the aminopeptidase N
           clade of E. coli and most other Proteobacteria, well
           separated phylogenetically within the M1 family. The M1
           family also includes leukotriene A-4
           hydrolase/aminopeptidase (with a bifunctional active
           site).
          Length = 831

 Score = 29.8 bits (67), Expect = 2.9
 Identities = 12/42 (28%), Positives = 17/42 (40%), Gaps = 2/42 (4%)

Query: 137 HKYGNAETKDFWSVLSKHSNHSINVKAIMDTWSRQMGFPVIR 178
           H +GNA   D    L+K S    ++ A  D W    G   + 
Sbjct: 409 HAFGNATLDDLIDSLAKASGR--DLSAWSDAWLETAGVNTLT 448


>gnl|CDD|218122 pfam04515, Choline_transpo, Plasma-membrane choline transporter.
           This family represents a high-affinity plasma-membrane
           choline transporter in C.elegans which is thought to be
           rate-limiting for ACh synthesis in cholinergic nerve
           terminals.
          Length = 327

 Score = 29.5 bits (67), Expect = 3.4
 Identities = 7/23 (30%), Positives = 13/23 (56%)

Query: 42  RALIIASVVLSILFLSSLIIAYV 64
           RAL+   +   +LFL  L ++ +
Sbjct: 241 RALVNDGLGGFVLFLGKLFVSAL 263


>gnl|CDD|189010 cd09603, M1_APN_4, Peptidase M1 family Aminopeptidase N.  This
           family contains mostly bacterial and some archaeal
           aminopeptidase N (APN; CD13; Alanyl aminopeptidase; EC
           3.4.11.2), a Type II integral membrane protease
           belonging to the M1 gluzincin family. APN consists of a
           small N-terminal cytoplasmic domain, a single
           transmembrane domain and a large extracellular
           ectodomain that contains the active site. It
           preferentially cleaves neutral amino acids from the
           N-terminus of oligopeptides and, in higher eukaryotes,
           is present in a variety of human tissues and cell types
           (leukocyte, fibroblast, endothelial and epithelial
           cells). APN expression is dysregulated in inflammatory
           diseases such as chronic pain, rheumatoid arthritis,
           multiple sclerosis, systemic sclerosis, systemic lupus
           erythematosus, polymyositis/dermatomyosytis and
           pulmonary sarcoidosis, and is enhanced in tumor cells
           such as melanoma, renal, prostate, pancreas, colon,
           gastric and thyroid cancers. It is predominantly
           expressed on stem cells and on cells of the granulocytic
           and monocytic lineages at distinct stages of
           differentiation, thus considered a marker of
           differentiation. Thus, APN inhibition may lead to the
           development of anti-cancer and anti-inflammatory drugs.
           APNs are also present in many pathogenic bacteria and
           represent potential drug targets, Some APNs have been
           used commercially, such as one from Lactococcus lactis
           used in the food industry. APN also serves as a receptor
           for coronaviruses, although the virus receptor
           interaction site seems to be distinct from the enzymatic
           site and aminopeptidase activity is not necessary for
           viral infection. APNs have also been extensively studied
           as putative Cry toxin receptors. Cry1 proteins are
           pore-forming toxins that bind to the midgut epithelial
           cell membrane of susceptible insect larvae, causing
           extensive damage. Several different toxins, including
           Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have
           been shown to bind to APNs; however, a direct role of
           APN in cytotoxicity has been yet to be firmly
           established.
          Length = 415

 Score = 29.5 bits (67), Expect = 3.7
 Identities = 12/42 (28%), Positives = 20/42 (47%), Gaps = 2/42 (4%)

Query: 134 TSSHKYGNAETKDFWSVLSKHSNHSINVKAIMDTWSRQMGFP 175
            + H+ GN  T+DF ++  + S    ++ A  D W    G P
Sbjct: 376 LAEHRGGNVTTEDFRALAEEVS--GRDLDAFFDQWLYGAGLP 415


>gnl|CDD|236903 PRK11380, PRK11380, hypothetical protein; Provisional.
          Length = 353

 Score = 29.1 bits (65), Expect = 3.7
 Identities = 21/81 (25%), Positives = 32/81 (39%), Gaps = 12/81 (14%)

Query: 186 HSSNS---STTPAPPPMIEYSATQTRFLL------TNEPYGRNDSKLLLPRSPYDYKWYV 236
           H +N+   +   AP  MI   A    F         N   G++ +KL+      D  W +
Sbjct: 196 HGANTFKANMEEAPEQMIALLAKLAVFPSDYISDCANHSSGKSPAKLIWA---ADLSWMI 252

Query: 237 PLSYYTDQTGYKEQEIVWMNM 257
            LS    Q G  E+E+ W  +
Sbjct: 253 SLSRTAFQAGTIEEELAWHYI 273


>gnl|CDD|189009 cd09602, M1_APN_3, Peptidase M1 family containing Aminopeptidase N.
            This family contains bacterial and eukaryotic
           aminopeptidase N (APN; CD13; Alanyl aminopeptidase; EC
           3.4.11.2), a Type II integral membrane protease
           belonging to the M1 gluzincin family. APN consists of a
           small N-terminal cytoplasmic domain, a single
           transmembrane domain and a large extracellular
           ectodomain that contains the active site.  It
           preferentially cleaves neutral amino acids from the
           N-terminus of oligopeptides and, in higher eukaryotes,
           is present in a variety of human tissues and cell types
           (leukocyte, fibroblast, endothelial and epithelial
           cells). APN expression is dysregulated in inflammatory
           diseases such as chronic pain, rheumatoid arthritis,
           multiple sclerosis, systemic sclerosis, systemic lupus
           erythematosus, polymyositis/dermatomyosytis and
           pulmonary sarcoidosis, and is enhanced in tumor cells
           such as melanoma, renal, prostate, pancreas, colon,
           gastric and thyroid cancers. It is predominantly
           expressed on stem cells and on cells of the granulocytic
           and monocytic lineages at distinct stages of
           differentiation, thus considered a marker of
           differentiation. Thus, APN inhibition may lead to the
           development of anti-cancer and anti-inflammatory drugs.
           APNs are also present in many pathogenic bacteria and
           represent potential drug targets, Some APNs have been
           used commercially, such as one from Lactococcus lactis
           used in the food industry. APN also serves as a receptor
           for coronaviruses, although the virus receptor
           interaction site seems to be distinct from the enzymatic
           site and aminopeptidase activity is not necessary for
           viral infection. APNs have also been extensively studied
           as putative Cry toxin receptors. Cry1 proteins are
           pore-forming toxins that bind to the midgut epithelial
           cell membrane of susceptible insect larvae, causing
           extensive damage. Several different toxins, including
           Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have
           been shown to bind to APNs; however, a direct role of
           APN in cytotoxicity has been yet to be firmly
           established.
          Length = 438

 Score = 29.5 bits (67), Expect = 3.9
 Identities = 10/36 (27%), Positives = 14/36 (38%), Gaps = 6/36 (16%)

Query: 137 HKYGNAETKDFWSVLSKHSNHSINVKAIMDTWSRQM 172
           H +GNA   DF   L + S         +  WS+  
Sbjct: 404 HAFGNATLADFLGALDEASGRD------LSAWSQVW 433


>gnl|CDD|131473 TIGR02420, dksA, RNA polymerase-binding protein DksA.  The model
           that is the basis for this family describes a small,
           pleiotropic protein, DksA (DnaK suppressor A),
           originally named as a multicopy suppressor of
           temperature sensitivity of dnaKJ mutants. DksA mutants
           are defective in quorum sensing, virulence, etc. DksA is
           now understood to bind RNA polymerase directly and
           modulate its response to small molecules to control the
           level of transcription of rRNA. Nearly all members of
           this family are in the Proteobacteria. Whether the
           closest homologs outside the Proteobacteria function
           equivalently is unknown. The low value set for the noise
           cutoff allows identification of possible DksA proteins
           from outside the proteobacteria. TIGR02419 describes a
           closely related family of short sequences usually found
           in prophage regions of proteobacterial genomes or in
           known phage [Transcription, Transcription factors,
           Regulatory functions, Small molecule interactions].
          Length = 110

 Score = 28.0 bits (63), Expect = 3.9
 Identities = 20/72 (27%), Positives = 33/72 (45%), Gaps = 10/72 (13%)

Query: 296 LEWERKYLHKI--MLKFL-NVVENIPEEGDIPSNIVRYCERFIEF-NSTRVPSERKLLLK 351
           L W+++ L +    L+ L    EN P+  D  +   +  ER +E     R   ERKL+ K
Sbjct: 14  LRWKQELLEEADKTLEHLQEESENFPDPADRAT---QEEERALELRTRDR---ERKLIKK 67

Query: 352 VKAFFKDMDVGS 363
           +    K ++ G 
Sbjct: 68  IDEALKRIEDGE 79


>gnl|CDD|240404 PTZ00402, PTZ00402, glutamyl-tRNA synthetase; Provisional.
          Length = 601

 Score = 29.2 bits (65), Expect = 4.4
 Identities = 27/88 (30%), Positives = 39/88 (44%), Gaps = 11/88 (12%)

Query: 143 ETKDFWSVLSKHSNHS----INVKAIMDTWSRQMGFPVIRISRITPQHSSNSSTTPAPP- 197
           ETK  W+ + K S       +  K  +D  ++ M  PVI    +TP H+   +   A P 
Sbjct: 174 ETKRLWNEMKKGSAEGQETCLRAKISVDNENKAMRDPVIYRVNLTP-HARQGTKYKAYPT 232

Query: 198 -----PMIEYSATQTRFLLTNEPYGRND 220
                P+I+     T  L TNE + RND
Sbjct: 233 YDFCCPIIDSVEGVTHALRTNEYHDRND 260


>gnl|CDD|182589 PRK10614, PRK10614, multidrug efflux system subunit MdtC;
           Provisional.
          Length = 1025

 Score = 28.9 bits (65), Expect = 5.9
 Identities = 26/77 (33%), Positives = 34/77 (44%), Gaps = 16/77 (20%)

Query: 78  VFLQDEDLNGAKRPV---IPIATSGEVFPWNNVRLPTSTGMP-RPKTSGVSSANIP-TIL 132
            F  D D+NGA R V   I  A S          LP  +GMP RP     + ++ P  IL
Sbjct: 94  QFDFDRDINGAARDVQAAINAAQS---------LLP--SGMPSRPTYRKANPSDAPIMIL 142

Query: 133 STSSHKYGNAETKDFWS 149
           + +S  Y   +  DF S
Sbjct: 143 TLTSDTYSQGQLYDFAS 159


>gnl|CDD|221257 pfam11838, DUF3358, Domain of unknown function (DUF3358).  This
           domain is functionally uncharacterized. This domain is
           found in eukaryotes and bacteria. This domain is found
           to the C-terminus of an aminopeptidase domain.
          Length = 323

 Score = 28.4 bits (64), Expect = 6.7
 Identities = 13/35 (37%), Positives = 19/35 (54%), Gaps = 2/35 (5%)

Query: 344 SERKLLLKVKAFFKDMDVGSGA--RSLEQSLETIE 376
           S  +LL +V+AF       +    RSL Q+L+TI 
Sbjct: 289 SSAELLDEVEAFLARKPKDTPGLRRSLAQALDTIR 323


>gnl|CDD|218031 pfam04335, VirB8, VirB8 protein.  VirB8 is a bacterial virulence
          protein with cytoplasmic, transmembrane, and
          periplasmic regions. It is thought that it is a primary
          constituent of a DNA transporter. The periplasmic
          region interacts with VirB9, VirB10, and itself. This
          family also includes the conjugal transfer protein
          family TrbF, a family of proteins known to be involved
          in conjugal transfer. The TrbF protein is thought to
          compose part of the pilus required for transfer. This
          domain has a similar fold to the NTF2 protein.
          Length = 208

 Score = 28.0 bits (63), Expect = 7.9
 Identities = 8/37 (21%), Positives = 17/37 (45%)

Query: 31 EHNGVAVCSQNRALIIASVVLSILFLSSLIIAYVGPQ 67
          +  G A   + R  ++A   L++  L+   +A + P 
Sbjct: 8  DRIGSARVQRRRWWLVAFGSLALAVLAVGAVAVLAPL 44


>gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope
           glycoprotein (BLLF1).  This family consists of the BLLF1
           viral late glycoprotein, also termed gp350/220. It is
           the most abundantly expressed glycoprotein in the viral
           envelope of the Herpesviruses and is the major antigen
           responsible for stimulating the production of
           neutralising antibodies in vivo.
          Length = 830

 Score = 28.2 bits (62), Expect = 8.9
 Identities = 22/114 (19%), Positives = 42/114 (36%), Gaps = 8/114 (7%)

Query: 92  VIPIATSGEVFPWNNVRLPTSTGMPRPKTSGVSSANIPTILSTSSHKYGNAETKDFWSVL 151
           VI + T   V P     +PT+  +P   T    S   PT  S +     ++   +  S  
Sbjct: 432 VIFVYTLVHVEPHKTTAVPTTPSLPPASTGPTVSTADPT--SGTPTGTTSSTLPEDTSPT 489

Query: 152 SKHSNHSINVKAIMDTWSRQMGFPVIRISRITPQHSSNSSTTPAPPPMIEYSAT 205
           S+ ++ + N  +                +  T Q +S++    +P P++    T
Sbjct: 490 SRTTSATPNATSPTPA------VTTPNATSPTTQKTSDTPNATSPTPIVIGVTT 537


  Database: CDD.v3.10
    Posted date:  Mar 20, 2013  7:55 AM
  Number of letters in database: 10,937,602
  Number of sequences in database:  44,354
  
Lambda     K      H
   0.317    0.133    0.407 

Gapped
Lambda     K      H
   0.267   0.0756    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 20,318,685
Number of extensions: 1934130
Number of successful extensions: 1872
Number of sequences better than 10.0: 1
Number of HSP's gapped: 1871
Number of HSP's successfully gapped: 25
Length of query: 398
Length of database: 10,937,602
Length adjustment: 99
Effective length of query: 299
Effective length of database: 6,546,556
Effective search space: 1957420244
Effective search space used: 1957420244
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 60 (26.8 bits)